Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Jang CY"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-13 z 13
    Tytuł:
    Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells
    Autorzy:
    Han NK
    Shin DH
    Kim JS
    Weon KY
    Jang CY
    Pokaż więcej
    Temat:
    gemcitabine
    liposome
    breast cancer stem cells
    hyaluronan
    targeting
    Medicine (General)
    R5-920
    Źródło:
    International Journal of Nanomedicine, Vol 2016, Iss default, Pp 1413-1425 (2016)
    Opis pliku:
    electronic resource
    Relacje:
    https://www.dovepress.com/hyaluronan-conjugated-liposomes-encapsulating-gemcitabine-for-breast-c-peer-reviewed-article-IJN; https://doaj.org/toc/1178-2013
    Dostęp URL:
    https://doaj.org/article/6e6218a78ad041b3b1be2f7de486a75a  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Letter to the Editor with # CTM2-2023-10-2488 entitled 'Antibody responses as correlates of protection against SARS-CoV-2 in the Omicron era: A 5-month prospective cohort study in Korean healthcare workers'.
    Autorzy:
    Lim SY; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Division of Infectious Diseases, Department of Internal Medicine, National Medical Center, Seoul, South Korea.
    Kim J; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, College of Medicine, Korea University, Seoul, South Korea.
    Kwon JS; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Kang SW; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Kim SB; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Kim W; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Son JY; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Jang CY; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Park H; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, College of Medicine, Korea University, Seoul, South Korea.
    Kim J; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, College of Medicine, Korea University, Seoul, South Korea.
    Lee S; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, College of Medicine, Korea University, Seoul, South Korea.
    Kim KT; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, College of Medicine, Korea University, Seoul, South Korea.
    Choi J; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, College of Medicine, Korea University, Seoul, South Korea.
    Kim JY; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Lim JS; Clinical Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Chang E; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Bae S; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Jung J; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Kim MJ; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Chong YP; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Lee SO; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Choi SH; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Kim YS; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Park MS; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, College of Medicine, Korea University, Seoul, South Korea.
    Kim SH; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
    Pokaż więcej
    Źródło:
    Clinical and translational medicine [Clin Transl Med] 2024 Jan; Vol. 14 (1), pp. e1551.
    Typ publikacji:
    Letter; Research Support, Non-U.S. Gov't
    MeSH Terms:
    SARS-CoV-2*
    COVID-19*
    Humans ; Antibody Formation ; Prospective Studies ; Republic of Korea/epidemiology
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Mutational analysis of severe acute respiratory syndrome coronavirus 2 in immunocompromised patients with persistent viral detection using whole genome sequencing.
    Autorzy:
    Chang E; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
    Lee J; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, Korea University College of Medicine, Seoul, Republic of Korea.
    Kim JW; Division of Emerging Virus and Vector Research, Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
    Seok JH; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, Korea University College of Medicine, Seoul, Republic of Korea.
    Bae JY; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, Korea University College of Medicine, Seoul, Republic of Korea.
    Kim J; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, Korea University College of Medicine, Seoul, Republic of Korea.
    Park H; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, Korea University College of Medicine, Seoul, Republic of Korea.
    Jang CY; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
    Kang SW; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
    Lim SY; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
    Kim JY; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
    Yang JS; Division of Emerging Virus and Vector Research, Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
    Kim KC; Division of Emerging Virus and Vector Research, Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
    Lee JY; Division of Emerging Virus and Vector Research, Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
    Park MS; Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, Korea University College of Medicine, Seoul, Republic of Korea.
    Kim SH; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
    Pokaż więcej
    Źródło:
    Clinical and translational medicine [Clin Transl Med] 2023 Nov; Vol. 13 (11), pp. e1462.
    Typ publikacji:
    Letter; Research Support, Non-U.S. Gov't
    MeSH Terms:
    SARS-CoV-2*/genetics
    COVID-19*/diagnosis
    COVID-19*/genetics
    Humans ; Whole Genome Sequencing ; Immunocompromised Host
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Gamma3 nail with U-Blade (RC) lag screw is effective with better surgical outcomes in trochanteric hip fractures.
    Autorzy:
    Han SB; Department of Orthopaedic Surgery, Korea University Anam Hospital, Korea University School of Medicine, Seoul, South Korea.
    Jung JK; Department of Orthopaedic Surgery, Korea University Anam Hospital, Korea University School of Medicine, Seoul, South Korea.
    Jang CY; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University School of Medicine, 22 Gwanpyeong-ro 170beon-gil, Dongan-gu, Anyang, 14068, South Korea.
    Kwak DK; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University School of Medicine, 22 Gwanpyeong-ro 170beon-gil, Dongan-gu, Anyang, 14068, South Korea.
    Kim JW; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University School of Medicine, 22 Gwanpyeong-ro 170beon-gil, Dongan-gu, Anyang, 14068, South Korea.
    Yoo JH; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University School of Medicine, 22 Gwanpyeong-ro 170beon-gil, Dongan-gu, Anyang, 14068, South Korea. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Apr 07; Vol. 10 (1), pp. 6021. Date of Electronic Publication: 2020 Apr 07.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Bone Nails*/adverse effects
    Bone Screws*/adverse effects
    Hip Fractures/*surgery
    Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Postoperative Complications/etiology ; Retrospective Studies ; Risk Factors ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Topical tranexamic acid in elderly patients with femoral neck fractures treated with hemiarthroplasty: efficacy and safety? - a case-control study.
    Autorzy:
    Kwak DK; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 896 Pyeongchon-dong, Dongan-gu, Anyang, 14068, South Korea.
    Jang CY; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 896 Pyeongchon-dong, Dongan-gu, Anyang, 14068, South Korea.
    Kim DH; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 896 Pyeongchon-dong, Dongan-gu, Anyang, 14068, South Korea.
    Rhyu SH; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 896 Pyeongchon-dong, Dongan-gu, Anyang, 14068, South Korea.
    Hwang JH; Department of Orthopaedic Surgery, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.
    Yoo JH; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 896 Pyeongchon-dong, Dongan-gu, Anyang, 14068, South Korea. .
    Pokaż więcej
    Źródło:
    BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2019 May 17; Vol. 20 (1), pp. 228. Date of Electronic Publication: 2019 May 17.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Femoral Neck Fractures/*surgery
    Hemiarthroplasty/*adverse effects
    Intraoperative Care/*methods
    Postoperative Hemorrhage/*prevention & control
    Tranexamic Acid/*administration & dosage
    Administration, Topical ; Aged ; Aged, 80 and over ; Blood Loss, Surgical/prevention & control ; Blood Loss, Surgical/statistics & numerical data ; Blood Transfusion/statistics & numerical data ; Case-Control Studies ; Female ; Femoral Neck Fractures/mortality ; Hospital Mortality ; Humans ; Incidence ; Intraoperative Care/adverse effects ; Intraoperative Care/statistics & numerical data ; Male ; Postoperative Hemorrhage/epidemiology ; Retrospective Studies ; Tranexamic Acid/adverse effects ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Perioperative antiplatelet in elderly patients aged over 70 years treated with proximal femur fracture: continue or discontinue?
    Autorzy:
    Jang CY; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 896 Pyeongchon-dong, Dongan-gu, Anyang, 431-070, Republic of Korea.
    Kwak DK; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 896 Pyeongchon-dong, Dongan-gu, Anyang, 431-070, Republic of Korea.
    Kim DH; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 896 Pyeongchon-dong, Dongan-gu, Anyang, 431-070, Republic of Korea.
    Lee HM; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 896 Pyeongchon-dong, Dongan-gu, Anyang, 431-070, Republic of Korea.
    Hwang JH; Department of Orthopaedic Surgery, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
    Yoo JH; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 896 Pyeongchon-dong, Dongan-gu, Anyang, 431-070, Republic of Korea. .
    Pokaż więcej
    Źródło:
    BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2019 Mar 25; Vol. 20 (1), pp. 124. Date of Electronic Publication: 2019 Mar 25.
    Typ publikacji:
    Journal Article; Observational Study
    MeSH Terms:
    Femoral Fractures/*drug therapy
    Hip Fractures/*drug therapy
    Perioperative Care/*methods
    Platelet Aggregation Inhibitors/*administration & dosage
    Postoperative Complications/*prevention & control
    Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Femoral Fractures/surgery ; Hip Fractures/surgery ; Humans ; Male ; Postoperative Complications/diagnosis ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Biomechanical Comparison of Three Different Intramedullary Nails for Fixation of Unstable Basicervical Intertrochanteric Fractures of the Proximal Femur: Experimental Studies.
    Autorzy:
    Kwak DK; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University School of Medicine, Anyang, Republic of Korea.
    Kim WH; Department of Biomedical Engineering, Inje University, Kimhae, Republic of Korea.
    Lee SJ; Department of Biomedical Engineering, Inje University, Kimhae, Republic of Korea.
    Rhyu SH; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University School of Medicine, Anyang, Republic of Korea.
    Jang CY; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University School of Medicine, Anyang, Republic of Korea.
    Yoo JH; Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University School of Medicine, Anyang, Republic of Korea.
    Pokaż więcej
    Źródło:
    BioMed research international [Biomed Res Int] 2018 Dec 11; Vol. 2018, pp. 7618079. Date of Electronic Publication: 2018 Dec 11 (Print Publication: 2018).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Bone Nails*
    Models, Anatomic*
    Femoral Neck Fractures/*surgery
    Femur Head/*surgery
    Osteoporosis/*surgery
    Femoral Neck Fractures/etiology ; Femoral Neck Fractures/pathology ; Femur Head/pathology ; Humans ; Osteoporosis/complications ; Osteoporosis/pathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Hepatic Metabolism of Sakuranetin and Its Modulating Effects on Cytochrome P450s and UDP-Glucuronosyltransferases.
    Autorzy:
    Jeong H; Graduate School of Biological Sciences, Sookmyung Women's University, Seoul 04310, Korea. .
    Lee J; Graduate School of Biological Sciences, Sookmyung Women's University, Seoul 04310, Korea. .
    Kim S; Graduate School of Biological Sciences, Sookmyung Women's University, Seoul 04310, Korea. .
    Yeo YY; Department of Biological Sciences and Research Institute of Women's Health, Sookmyung Women's University, Seoul 04310, Korea. .
    So H; Department of Biological Sciences and Research Institute of Women's Health, Sookmyung Women's University, Seoul 04310, Korea. .
    Wu H; Center for Research and Development of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. .
    Song YS; College of Pharmacy, Sookmyung Women's University, Seoul 04310, Korea. .
    Jang CY; College of Pharmacy, Sookmyung Women's University, Seoul 04310, Korea. .
    Kim HD; College of Pharmacy, Sookmyung Women's University, Seoul 04310, Korea. .
    Kim MJ; Department of Biological Sciences and Research Institute of Women's Health, Sookmyung Women's University, Seoul 04310, Korea. .
    Chang M; Department of Biological Sciences and Research Institute of Women's Health, Sookmyung Women's University, Seoul 04310, Korea. .
    Pokaż więcej
    Źródło:
    Molecules (Basel, Switzerland) [Molecules] 2018 Jun 26; Vol. 23 (7). Date of Electronic Publication: 2018 Jun 26.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Cytochrome P-450 Enzyme System/*metabolism
    Flavonoids/*metabolism
    Glucuronosyltransferase/*metabolism
    Liver/*metabolism
    Animals ; Chromatography, High Pressure Liquid ; Cytochrome P-450 Enzyme Inhibitors/pharmacology ; Cytochrome P-450 Enzyme System/genetics ; Hep G2 Cells ; Humans ; Liver/drug effects ; Metabolic Detoxication, Phase I ; Metabolic Detoxication, Phase II ; Metabolome ; Microsomes, Liver/drug effects ; Microsomes, Liver/metabolism ; NADP/metabolism ; Pregnane X Receptor ; Promoter Regions, Genetic/genetics ; Receptors, Steroid/metabolism ; Transcriptional Activation/genetics ; Uridine Diphosphate Glucuronic Acid/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    TC Mps1 12, a novel Mps1 inhibitor, suppresses the growth of hepatocellular carcinoma cells via the accumulation of chromosomal instability.
    Autorzy:
    Choi M; Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
    Min YH; Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
    Pyo J; Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
    Lee CW; Department of Molecular Cell Biology, School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea.
    Jang CY; College of Pharmacy, Sookmyung Women's University, Seoul, Republic of Korea.
    Kim JE; Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.; East-West Medical Research Institute, Kyung Hee University, Seoul, Republic of Korea.; Department of Pharmacology, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.
    Pokaż więcej
    Źródło:
    British journal of pharmacology [Br J Pharmacol] 2017 Jun; Vol. 174 (12), pp. 1810-1825. Date of Electronic Publication: 2017 Apr 22.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Antineoplastic Agents/*pharmacology
    Carcinoma, Hepatocellular/*drug therapy
    Cell Cycle Proteins/*antagonists & inhibitors
    Chromosomal Instability/*drug effects
    Liver Neoplasms/*drug therapy
    Protein Kinase Inhibitors/*pharmacology
    Protein Serine-Threonine Kinases/*antagonists & inhibitors
    Protein-Tyrosine Kinases/*antagonists & inhibitors
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/chemistry ; Carcinoma, Hepatocellular/pathology ; Cell Cycle Proteins/genetics ; Cell Cycle Proteins/metabolism ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Female ; Humans ; Ligands ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Protein Kinase Inhibitors/chemistry ; Protein Serine-Threonine Kinases/genetics ; Protein Serine-Threonine Kinases/metabolism ; Protein-Tyrosine Kinases/genetics ; Protein-Tyrosine Kinases/metabolism ; Structure-Activity Relationship ; Tumor Cells, Cultured ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry.
    Autorzy:
    Seki A; Department of Biological Sciences, Stanford University, Stanford, CA 94305-5020, USA.
    Coppinger JA
    Jang CY
    Yates JR
    Fang G
    Pokaż więcej
    Źródło:
    Science (New York, N.Y.) [Science] 2008 Jun 20; Vol. 320 (5883), pp. 1655-8.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Mitosis*
    Cell Cycle Proteins/*metabolism
    Protein Serine-Threonine Kinases/*metabolism
    Proto-Oncogene Proteins/*metabolism
    Animals ; Aurora Kinases ; CDC2 Protein Kinase/metabolism ; Cell Cycle Proteins/chemistry ; Cell Line ; Enzyme Activation ; Feedback, Physiological ; G2 Phase ; HeLa Cells ; Humans ; Kinetics ; Phosphorylation ; Protein Binding ; Protein Serine-Threonine Kinases/chemistry ; Protein Structure, Tertiary ; Proto-Oncogene Proteins/chemistry ; Recombinant Fusion Proteins/metabolism ; Xenopus ; Xenopus Proteins/metabolism ; Polo-Like Kinase 1
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-13 z 13

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies